TRxADE GROUP, INC. REPORTS 2019 RESULTS
30 mars 2020 08h05 HE
|
Trxade Group, Inc.
Delivered 2019 annual revenues of $7.43 Million (94.1% increase)Total Adjusted EBITDA of $852,647 (249% increase)Launched next generation of Telehealth Platform ( www.Bonumhealth.com ) Launched Drug...
TRxADE GROUP, INC. Announces Exercise of Overallotment Option by Underwriters
24 févr. 2020 08h00 HE
|
Trxade Group, Inc.
TAMPA, FL, Feb. 24, 2020 (GLOBE NEWSWIRE) -- Trxade Group, Inc., (Nasdaq: MEDS)(“Trxade Group” or the “Company”), an integrated drug procurement, delivery and healthcare platform that enables price...
TRxADE GROUP, INC. Announces Closing of Firm Commitment Common Stock Offering
18 févr. 2020 15h50 HE
|
Trxade Group, Inc.
TAMPA, FL, Feb. 18, 2020 (GLOBE NEWSWIRE) -- Trxade Group, Inc., (Nasdaq: MEDS)(“Trxade Group” or the “Company”), an integrated drug procurement, delivery and healthcare platform that enables price...
TRxADE GROUP, INC. Announces Uplisting to Nasdaq Capital Market, Pricing of $5.2 Million Firm Commitment Public Offering of Common Stock and Effectiveness of Reverse Stock Split
13 févr. 2020 09h10 HE
|
Trxade Group, Inc.
Ticker Symbol Change to “MEDS” TAMPA, FL, Feb. 13, 2020 (GLOBE NEWSWIRE) -- Trxade Group, Inc., (Nasdaq: MEDS) (OTCQB: TRXD) (“Trxade Group” or the “Company”), an integrated drug procurement,...